Table of Contents Author Guidelines Submit a Manuscript
Oxidative Medicine and Cellular Longevity
Volume 2017 (2017), Article ID 3940241, 16 pages
https://doi.org/10.1155/2017/3940241
Review Article

Ischemic Retinopathies: Oxidative Stress and Inflammation

1Department of Ophthalmology, Maisonneuve-Rosemont Hospital Research Center, University of Montréal, Montréal, QC, Canada
2Department of Pediatrics, Ophthalmology and Pharmacology, Centre Hospitalier Universitaire Sainte-Justine Research Center, Montréal, QC, Canada

Correspondence should be addressed to José Carlos Rivera; ac.laertnomu@arevir.cj and Sylvain Chemtob; ac.laertnomu@botmehc.niavlys

Received 17 September 2017; Accepted 20 November 2017; Published 19 December 2017

Academic Editor: Alexandra S. Latini

Copyright © 2017 José Carlos Rivera et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. J. H. Kempen, B. J. O’Colmain, C. Leske et al., “The prevalence of diabetic retinopathy among adults in the United States,” Archives of Ophthalmology, vol. 122, pp. 552–563, 2004. View at Publisher · View at Google Scholar · View at Scopus
  2. C. Gilbert, J. Rahi, M. Eckstein, J. O'Sullivan, and A. Foster, “Retinopathy of prematurity in middle-income countries,” Lancet, vol. 350, no. 9070, pp. 12–14, 1997. View at Publisher · View at Google Scholar · View at Scopus
  3. P. Sapieha, D. Hamel, Z. Shao et al., “Proliferative retinopathies: angiogenesis that blinds,” The International Journal of Biochemistry & Cell Biology, vol. 42, no. 1, pp. 5–12, 2010. View at Publisher · View at Google Scholar · View at Scopus
  4. A. B. Fulton, R. M. Hansen, A. Moskowitz, and J. D. Akula, “The neurovascular retina in retinopathy of prematurity,” Progress in Retinal and Eye Research, vol. 28, no. 6, pp. 452–482, 2009. View at Publisher · View at Google Scholar · View at Scopus
  5. Y. Wu, L. Tang, and B. Chen, “Oxidative stress: implications for the development of diabetic retinopathy and antioxidant therapeutic perspectives,” Oxidative Medicine and Cellular Longevity, vol. 2014, Article ID 752387, 12 pages, 2014. View at Publisher · View at Google Scholar · View at Scopus
  6. P. X. Shaw, T. Stiles, C. Douglas et al., “Oxidative stress, innate immunity, and age-related macular degeneration,” AIMS Molecular Science, vol. 3, no. 2, pp. 196–221, 2016. View at Publisher · View at Google Scholar
  7. J. Lee and O. Dammann, “Perinatal infection, inflammation, and retinopathy of prematurity,” Seminars in Fetal & Neonatal Medicine, vol. 17, no. 1, pp. 26–29, 2012. View at Publisher · View at Google Scholar · View at Scopus
  8. F. Semeraro, A. Cancarini, R. dell'Omo, S. Rezzola, M. R. Romano, and C. Costagliola, “Diabetic retinopathy: vascular and inflammatory disease,” Journal of Diabetes Research, vol. 2015, Article ID 582060, 16 pages, 2015. View at Publisher · View at Google Scholar · View at Scopus
  9. S. G. Jarrett and M. E. Boulton, “Consequences of oxidative stress in age-related macular degeneration,” Molecular Aspects of Medicine, vol. 33, no. 4, pp. 399–417, 2012. View at Publisher · View at Google Scholar · View at Scopus
  10. K. Haskins, B. Bradley, K. Powers et al., “Oxidative stress in type 1 diabetes,” Annals of the New York Academy of Sciences, vol. 1005, no. 1, pp. 43–54, 2003. View at Publisher · View at Google Scholar · View at Scopus
  11. H. Wang, S. X. Zhang, and M. E. Hartnett, “Signaling pathways triggered by oxidative stress that mediate features of severe retinopathy of prematurity,” JAMA Ophthalmology, vol. 131, no. 1, pp. 80–85, 2013. View at Publisher · View at Google Scholar · View at Scopus
  12. R. A. Kowluru, J. Tang, and T. S. Kern, “Abnormalities of retinal metabolism in diabetes and experimental galactosemia: VII. Effect of long-term administration of antioxidants on the development of retinopathy,” Diabetes, vol. 50, no. 8, pp. 1938–1942, 2001. View at Publisher · View at Google Scholar
  13. M. Brownlee, “The pathobiology of diabetic complications: a unifying mechanism,” Diabetes, vol. 54, no. 6, pp. 1615–1625, 2005. View at Publisher · View at Google Scholar · View at Scopus
  14. H. Blencowe, J. E. Lawn, T. Vazquez, A. Fielder, and C. Gilbert, “Preterm-associated visual impairment and estimates of retinopathy of prematurity at regional and global levels for 2010,” Pediatric Research, vol. 74, Supplement 1, pp. 35–49, 2013. View at Publisher · View at Google Scholar · View at Scopus
  15. K. Gergely and A. Gerinec, “Retinopathy of prematurity--epidemics, incidence, prevalence, blindness,” Bratislavske Lekarske Listy, vol. 111, no. 9, pp. 514–517, 2010. View at Google Scholar
  16. A. Hellström, E. Engström, A.-L. Hård et al., “Postnatal serum insulin-like growth factor I deficiency is associated with retinopathy of prematurity and other complications of premature birth,” Pediatrics, vol. 112, no. 5, pp. 1016–1020, 2003. View at Publisher · View at Google Scholar · View at Scopus
  17. J. C. Rivera, P. Sapieha, J. S. Joyal et al., “Understanding retinopathy of prematurity: update on pathogenesis,” Neonatology, vol. 100, no. 4, pp. 343–353, 2011. View at Publisher · View at Google Scholar · View at Scopus
  18. G. Holmstrom, A. Hellstrom, P. Jakobsson, P. Lundgren, K. Tornqvist, and A. Wallin, “Evaluation of new guidelines for ROP screening in Sweden using SWEDROP - a national quality register,” Acta Ophthalmologica, vol. 93, no. 3, pp. 265–268, 2015. View at Publisher · View at Google Scholar · View at Scopus
  19. M. H. Beauchamp, F. Sennlaub, G. Speranza et al., “Redox-dependent effects of nitric oxide on microvascular integrity in oxygen-induced retinopathy,” Free Radical Biology & Medicine, vol. 37, no. 11, pp. 1885–1894, 2004. View at Publisher · View at Google Scholar · View at Scopus
  20. X. Gu, A. B. El-Remessy, S. E. Brooks, M. Al-Shabrawey, N. T. Tsai, and R. B. Caldwell, “Hyperoxia induces retinal vascular endothelial cell apoptosis through formation of peroxynitrite,” American Journal of Physiology Cell Physiology, vol. 285, no. 3, pp. C546–C554, 2003. View at Publisher · View at Google Scholar
  21. S. E. Brooks, X. Gu, S. Samuel et al., “Reduced severity of oxygen-induced retinopathy in eNOS-deficient mice,” Investigative Ophthalmology & Visual Science, vol. 42, no. 1, pp. 222–228, 2001. View at Google Scholar
  22. E. Kermorvant-Duchemin, F. Sennlaub, M. Sirinyan et al., “Trans-arachidonic acids generated during nitrative stress induce a thrombospondin-1-dependent microvascular degeneration,” Nature Medicine, vol. 11, no. 12, pp. 1339–1345, 2005. View at Publisher · View at Google Scholar · View at Scopus
  23. M. H. Beauchamp, A. K. Martinez-Bermudez, F. Gobeil Jr et al., “Role of thromboxane in retinal microvascular degeneration in oxygen-induced retinopathy,” Journal of Applied Physiology, vol. 90, no. 6, pp. 2279–2288, 2001. View at Google Scholar
  24. M. Balazy and S. Chemtob, “Trans-arachidonic acids: new mediators of nitro-oxidative stress,” Pharmacology & Therapeutics, vol. 119, no. 3, pp. 275–290, 2008. View at Publisher · View at Google Scholar · View at Scopus
  25. J. C. Honore, A. Kooli, D. Hamel et al., “Fatty acid receptor Gpr40 mediates neuromicrovascular degeneration induced by transarachidonic acids in rodents,” Arteriosclerosis, Thrombosis, and Vascular Biology, vol. 33, no. 5, pp. 954–961, 2013. View at Publisher · View at Google Scholar · View at Scopus
  26. M. H. Beauchamp, A. M. Marrache, X. Hou et al., “Platelet-activating factor in vasoobliteration of oxygen-induced retinopathy,” Investigative Ophthalmology & Visual Science, vol. 43, no. 10, pp. 3327–3337, 2002. View at Google Scholar
  27. S. Brault, F. Gobeil Jr., A. Fortier et al., “Lysophosphatidic acid induces endothelial cell death by modulating the redox environment,” AJP: Regulatory, Integrative and Comparative Physiology, vol. 292, pp. R1174–R1183, 2007. View at Publisher · View at Google Scholar · View at Scopus
  28. S. Perrone, S. Negro, M. L. Tataranno, and G. Buonocore, “Oxidative stress and antioxidant strategies in newborns,” The Journal of Maternal-Fetal & Neonatal Medicine, vol. 23, Supplement 3, pp. 63–65, 2010. View at Publisher · View at Google Scholar · View at Scopus
  29. S. Y. Shim and H. S. Kim, “Oxidative stress and the antioxidant enzyme system in the developing brain,” Korean Journal of Pediatrics, vol. 56, pp. 107–111, 2013. View at Publisher · View at Google Scholar · View at Scopus
  30. J. C. Nielsen, M. I. Naash, and R. E. Anderson, “The regional distribution of vitamins E and C in mature and premature human retinas,” Investigative Ophthalmology & Visual Science, vol. 29, no. 1, pp. 22–26, 1988. View at Google Scholar
  31. H. M. Hittner, A. J. Rudolph, and F. L. Kretzer, “Suppression of severe retinopathy of prematurity with vitamin E supplementation. Ultrastructural mechanism of clinical efficacy,” Ophthalmology, vol. 91, no. 12, pp. 1512–1523, 1984. View at Publisher · View at Google Scholar
  32. T. N. Raju, P. Langenberg, V. Bhutani, and G. E. Quinn, “Vitamin E prophylaxis to reduce retinopathy of prematurity: a reappraisal of published trials,” The Journal of Pediatrics, vol. 131, no. 6, pp. 844–850, 1997. View at Publisher · View at Google Scholar · View at Scopus
  33. D. P. Muller, “Vitamin E therapy in retinopathy of prematurity,” Eye, vol. 6, no. 2, pp. 221–225, 1992. View at Publisher · View at Google Scholar · View at Scopus
  34. L. P. Brion, E. F. Bell, and T. S. Raghuveer, “Vitamin E supplementation for prevention of morbidity and mortality in preterm infants,” Cochrane Database of Systematic Reviews, no. 4, article CD003665, 2003. View at Publisher · View at Google Scholar
  35. B. Halliwell, “Vitamin C: antioxidant or pro-oxidant in vivo?” Free Radical Research, vol. 25, no. 5, pp. 439–454, 1996. View at Publisher · View at Google Scholar
  36. M. L. Streeter and P. Rosso, “Transport mechanisms for ascorbic acid in the human placenta,” The American Journal of Clinical Nutrition, vol. 34, no. 9, pp. 1706–1711, 1981. View at Google Scholar
  37. B. M. Hamil, B. Munks, E. Z. Moyer, M. Kaucher, and H. H. Williams, “Vitamin C in the blood and urine of the newborn and in the cord and maternal blood,” American Journal of Diseases of Children, vol. 74, no. 4, pp. 417–433, 1947. View at Publisher · View at Google Scholar
  38. T. M. R. N. Berger, M. E. Avery, and B. Frei, “Vitamin C in premature and full-term human neonates,” Redox Report, vol. 2, no. 4, pp. 257–262, 1996. View at Publisher · View at Google Scholar
  39. “Nutrient needs and feeding of premature infants. Nutrition Committee, Canadian Paediatric Society,” CMAJ: Canadian Medical Association Journal, vol. 152, no. 11, pp. 1765–1785, 1995.
  40. K. M. Silvers, A. T. Gibson, and H. J. Powers, “High plasma vitamin C concentrations at birth associated with low antioxidant status and poor outcome in premature infants,” Archives of Disease in Childhood Fetal and Neonatal Edition, vol. 71, no. 1, pp. F40–F44, 1994. View at Publisher · View at Google Scholar
  41. K. M. Silvers, A. T. Gibson, J. M. Russell, and H. J. Powers, “Antioxidant activity, packed cell transfusions, and outcome in premature infants,” Archives of Disease in Childhood Fetal and Neonatal Edition, vol. 78, no. 3, pp. F214–F219, 1998. View at Publisher · View at Google Scholar
  42. R. M. Moison, D. Vanzoerengrobben, A. A. Haasnoot, and H. Berger, “Early biochemical detection of bronchopulmonary dysplasia (BPD) in preterm babies,” Pediatric Research, vol. 37, no. 4, pp. A343–A343, 1995. View at Google Scholar
  43. K. B. Sluis, T. Inder, and A. Wilkinson, “Plasma and endotracheal vitamin C concentrations in premature infants: relationship to outcome measures,” in Proceedings of the 14th Annual Congress of the Australian Perinatal Society, 1996.
  44. B. A. Darlow, H. Buss, F. McGill, L. Fletcher, P. Graham, and C. C. Winterbourn, “Vitamin C supplementation in very preterm infants: a randomised controlled trial,” Archives of Disease in Childhood - Fetal and Neonatal Edition, vol. 90, pp. F117–F122, 2005. View at Publisher · View at Google Scholar · View at Scopus
  45. M. L. Chen, E. N. Allred, J. L. Hecht et al., “Placenta microbiology and histology, and the risk for severe retinopathy of prematurity,” Investigative Opthalmology & Visual Science, vol. 52, pp. 7052–7058, 2011. View at Publisher · View at Google Scholar · View at Scopus
  46. K. W. Tolsma, E. N. Allred, M. L. Chen, J. Duker, A. Leviton, and O. Dammann, “Neonatal bacteremia and retinopathy of prematurity: the ELGAN study,” Archives of Ophthalmology, vol. 129, pp. 1555–1563, 2011. View at Publisher · View at Google Scholar · View at Scopus
  47. S. Tremblay, K. Miloudi, S. Chaychi et al., “Systemic inflammation perturbs developmental retinal angiogenesis and neuroretinal function,” Investigative Opthalmology & Visual Science, vol. 54, pp. 8125–8139, 2013. View at Publisher · View at Google Scholar
  48. H. K. Hong, H. J. Lee, J. H. Ko et al., “Neonatal systemic inflammation in rats alters retinal vessel development and simulates pathologic features of retinopathy of prematurity,” Journal of Neuroinflammation, vol. 11, p. 87, 2014. View at Publisher · View at Google Scholar · View at Scopus
  49. J. C. Rivera, B. Noueihed, A. Madaan et al., “Tetrahydrobiopterin (BH4) deficiency is associated with augmented inflammation and microvascular degeneration in the retina,” Journal of Neuroinflammation, vol. 14, no. 1, p. 181, 2017. View at Publisher · View at Google Scholar
  50. K. S. Edgar, N. Matesanz, T. A. Gardiner, Z. S. Katusic, and D. M. McDonald, “Hyperoxia depletes (6R)-5,6,7,8-tetrahydrobiopterin levels in the neonatal retina: implications for nitric oxide synthase function in retinopathy,” The American Journal of Pathology, vol. 185, no. 6, pp. 1769–1782, 2015. View at Publisher · View at Google Scholar · View at Scopus
  51. J. C. Rivera, M. Holm, D. Austeng et al., “Retinopathy of prematurity: inflammation, choroidal degeneration, and novel promising therapeutic strategies,” Journal of Neuroinflammation, vol. 14, no. 1, p. 165, 2017. View at Publisher · View at Google Scholar
  52. C. Gabay and I. Kushner, “Acute-phase proteins and other systemic responses to inflammation,” New England Journal of Medicine, vol. 340, no. 6, pp. 448–454, 1999. View at Publisher · View at Google Scholar · View at Scopus
  53. V. Sivakumar, W. S. Foulds, C. D. Luu, E. A. Ling, and C. Kaur, “Retinal ganglion cell death is induced by microglia derived pro-inflammatory cytokines in the hypoxic neonatal retina,” The Journal of Pathology, vol. 224, no. 2, pp. 245–260, 2011. View at Publisher · View at Google Scholar · View at Scopus
  54. J. C. Rivera, N. Sitaras, B. Noueihed et al., “Microglia and interleukin-1beta in ischemic retinopathy elicit microvascular degeneration through neuronal semaphorin-3A,” Arteriosclerosis, Thrombosis, and Vascular Biology, vol. 33, no. 8, pp. 1881–1891, 2013. View at Publisher · View at Google Scholar · View at Scopus
  55. T. E. Zhou, J. C. Rivera, V. K. Bhosle et al., “Choroidal involution is associated with a progressive degeneration of the outer retinal function in a model of retinopathy of prematurity,” The American Journal of Pathology, vol. 186, no. 12, pp. 3100–3116, 2016. View at Publisher · View at Google Scholar · View at Scopus
  56. S. M. Opal and V. A. DePalo, “Anti-inflammatory cytokines,” Chest, vol. 117, no. 4, pp. 1162–1172, 2000. View at Publisher · View at Google Scholar
  57. D. S. Dace, A. A. Khan, J. Kelly, and R. S. Apte, “Interleukin-10 promotes pathological angiogenesis by regulating macrophage response to hypoxia during development,” PLoS One, vol. 3, no. 10, article e3381, 2008. View at Publisher · View at Google Scholar · View at Scopus
  58. S. G. Kremlev and C. Palmer, “Interleukin-10 inhibits endotoxin-induced pro-inflammatory cytokines in microglial cell cultures,” Journal of Neuroimmunology, vol. 162, no. 1-2, pp. 71–80, 2005. View at Publisher · View at Google Scholar · View at Scopus
  59. S. Rodts-Palenik, J. Wyatt-Ashmead, Y. Pang et al., “Maternal infection-induced white matter injury is reduced by treatment with interleukin-10,” American Journal of Obstetrics and Gynecology, vol. 191, no. 4, pp. 1387–1392, 2004. View at Publisher · View at Google Scholar · View at Scopus
  60. M. Dordelmann, J. Kerk, F. Dressler et al., “Interleukin-10 high producer allele and ultrasound-defined periventricular white matter abnormalities in preterm infants: a preliminary study,” Neuropediatrics, vol. 37, no. 03, pp. 130–136, 2006. View at Publisher · View at Google Scholar · View at Scopus
  61. H. Ghasemi, T. Ghazanfari, R. Yaraee, S. Faghihzadeh, and Z. M. Hassan, “Roles of IL-8 in ocular inflammations: a review,” Ocular Immunology and Inflammation, vol. 19, no. 6, pp. 401–412, 2011. View at Publisher · View at Google Scholar · View at Scopus
  62. R. C. Silveira, J. B. Fortes Filho, and R. S. Procianoy, “Assessment of the contribution of cytokine plasma levels to detect retinopathy of prematurity in very low birth weight infants,” Investigative Ophthalmology & Visual Science, vol. 52, no. 3, pp. 1297–1301, 2011. View at Publisher · View at Google Scholar · View at Scopus
  63. M. R. Powers, M. H. Davies, and J. P. Eubanks, “Increased expression of chemokine KC, an interleukin-8 homologue, in a model of oxygen-induced retinopathy,” Current Eye Research, vol. 30, no. 4, pp. 299–307, 2005. View at Publisher · View at Google Scholar · View at Scopus
  64. T. Sato, S. Kusaka, H. Shimojo, and T. Fujikado, “Simultaneous analyses of vitreous levels of 27 cytokines in eyes with retinopathy of prematurity,” Ophthalmology, vol. 116, no. 11, pp. 2165–2169, 2009. View at Publisher · View at Google Scholar · View at Scopus
  65. G. Hellgren, K. Willett, E. Engstrom et al., “Proliferative retinopathy is associated with impaired increase in BDNF and RANTES expression levels after preterm birth,” Neonatology, vol. 98, no. 4, pp. 409–418, 2010. View at Publisher · View at Google Scholar · View at Scopus
  66. B. G. Sood, A. Madan, S. Saha et al., “Perinatal systemic inflammatory response syndrome and retinopathy of prematurity,” Pediatric Research, vol. 67, no. 4, pp. 394–400, 2010. View at Publisher · View at Google Scholar · View at Scopus
  67. Y. Yao and S. E. Tsirka, “Monocyte chemoattractant protein-1 and the blood-brain barrier,” Cellular and Molecular Life Sciences, vol. 71, no. 4, pp. 683–697, 2014. View at Publisher · View at Google Scholar · View at Scopus
  68. H. Yu, L. Yuan, Y. Zou et al., “Serum concentrations of cytokines in infants with retinopathy of prematurity,” APMIS, vol. 122, no. 9, pp. 818–823, 2014. View at Publisher · View at Google Scholar · View at Scopus
  69. T. Yoshimura, K. H. Sonoda, M. Sugahara et al., “Comprehensive analysis of inflammatory immune mediators in vitreoretinal diseases,” PLoS One, vol. 4, no. 12, article e8158, 2009. View at Publisher · View at Google Scholar · View at Scopus
  70. S. Rusnak, J. Vrzalova, M. Sobotova, L. Hecova, R. Ricarova, and O. Topolcan, “The measurement of intraocular biomarkers in various stages of proliferative diabetic retinopathy using multiplex xMAP technology,” Journal of Ophthalmology, vol. 2015, Article ID 424783, 6 pages, 2015. View at Publisher · View at Google Scholar · View at Scopus
  71. S. Yoshida, A. Yoshida, T. Ishibashi, S. G. Elner, and V. M. Elner, “Role of MCP-1 and MIP-1alpha in retinal neovascularization during postischemic inflammation in a mouse model of retinal neovascularization,” Journal of Leukocyte Biology, vol. 73, no. 1, pp. 137–144, 2003. View at Publisher · View at Google Scholar · View at Scopus
  72. S. Yoshida, A. Yoshida, and T. Ishibashi, “Induction of IL-8, MCP-1, and bFGF by TNF-alpha in retinal glial cells: implications for retinal neovascularization during post-ischemic inflammation,” Graefe's Archive for Clinical and Experimental Ophthalmology, vol. 242, no. 5, pp. 409–413, 2004. View at Publisher · View at Google Scholar · View at Scopus
  73. L. D. Waterbury, D. Silliman, and T. Jolas, “Comparison of cyclooxygenase inhibitory activity and ocular anti-inflammatory effects of ketorolac tromethamine and bromfenac sodium,” Current Medical Research and Opinion, vol. 22, no. 6, pp. 1133–1140, 2006. View at Publisher · View at Google Scholar · View at Scopus
  74. U. Acar, D. E. Acar, C. Tanriverdi et al., “Prostaglandin E2 levels of aqueous and vitreous humor in ketorolac 0.4% and nepafenac 0.1% administered healthy rabbits,” Ocular Immunology and Inflammation, vol. 25, no. 3, pp. 323–327, 2017. View at Publisher · View at Google Scholar · View at Scopus
  75. M. Avila-Vazquez, R. Maffrand, M. Sosa et al., “Treatment of retinopathy of prematurity with topical ketorolac tromethamine: a preliminary study,” BMC Pediatrics, vol. 4, no. 1, p. 15, 2004. View at Publisher · View at Google Scholar · View at Scopus
  76. R. D. Higgins, A. L. Mendelsohn, M. J. DeFeo, R. Ucsel, and K. D. Hendricks-Munoz, “Antenatal dexamethasone and decreased severity of retinopathy of prematurity,” Archives of Ophthalmology, vol. 116, no. 5, pp. 601–605, 1998. View at Publisher · View at Google Scholar
  77. L. W. Doyle, R. A. Ehrenkranz, and H. L. Halliday, “Dexamethasone treatment in the first week of life for preventing bronchopulmonary dysplasia in preterm infants: a systematic review,” Neonatology, vol. 98, no. 3, pp. 217–224, 2010. View at Publisher · View at Google Scholar · View at Scopus
  78. A. R. Stark, W. A. Carlo, J. E. Tyson et al., “Adverse effects of early dexamethasone treatment in extremely-low-birth-weight infants. National Institute of Child Health and Human Development Neonatal Research Network,” New England Journal of Medicine, vol. 344, no. 2, pp. 95–101, 2001. View at Publisher · View at Google Scholar · View at Scopus
  79. B. Schmidt, R. S. Roberts, P. Davis et al., “Long-term effects of caffeine therapy for apnea of prematurity,” New England Journal of Medicine, vol. 357, no. 19, pp. 1893–1902, 2007. View at Publisher · View at Google Scholar · View at Scopus
  80. N. Sahir, P. Evrard, and P. Gressens, “Caffeine induces sonic hedgehog gene expression in cultured astrocytes and neurons,” Journal of Molecular Neuroscience, vol. 24, no. 2, pp. 201–206, 2004. View at Publisher · View at Google Scholar · View at Scopus
  81. W. H. Liu and L. S. Chang, “Caffeine induces matrix metalloproteinase-2 (MMP-2) and MMP-9 down-regulation in human leukemia U937 cells via Ca2+/ROS-mediated suppression of ERK/c-fos pathway and activation of p38 MAPK/c-jun pathway,” Journal of Cellular Physiology, vol. 224, no. 3, pp. 775–785, 2010. View at Publisher · View at Google Scholar · View at Scopus
  82. S. D. Varma, K. R. Hegde, and S. Kovtun, “Oxidative stress in lens in vivo: inhibitory effect of caffeine. A preliminary report,” Molecular Vision, vol. 16, pp. 501–505, 2010. View at Google Scholar
  83. K. M. Connor, J. P. SanGiovanni, C. Lofqvist et al., “Increased dietary intake of omega-3-polyunsaturated fatty acids reduces pathological retinal angiogenesis,” Nature Medicine, vol. 13, no. 7, pp. 868–873, 2007. View at Publisher · View at Google Scholar · View at Scopus
  84. A. Qawasmi, A. Landeros-Weisenberger, and M. H. Bloch, “Meta-analysis of LCPUFA supplementation of infant formula and visual acuity,” Pediatrics, vol. 131, no. 1, pp. e262–e272, 2013. View at Publisher · View at Google Scholar · View at Scopus
  85. D. Pawlik, R. Lauterbach, M. Walczak, J. Hurkala, and M. P. Sherman, “Fish-oil fat emulsion supplementation reduces the risk of retinopathy in very low birth weight infants: a prospective, randomized study,” JPEN Journal of Parenteral and Enteral Nutrition, vol. 38, no. 6, pp. 711–716, 2014. View at Publisher · View at Google Scholar · View at Scopus
  86. N. Cheung, P. Mitchell, and T. Y. Wong, “Diabetic retinopathy,” Lancet, vol. 376, no. 9735, pp. 124–136, 2010. View at Publisher · View at Google Scholar · View at Scopus
  87. K. Ogurtsova, J. D. da Rocha Fernandes, Y. Huang et al., “Global estimates for the prevalence of diabetes for 2015 and 2040,” Diabetes Research and Clinical Practice, vol. 128, pp. 40–50, 2017. View at Publisher · View at Google Scholar
  88. Y. Zheng, M. He, and N. Congdon, “The worldwide epidemic of diabetic retinopathy,” Indian Journal of Ophthalmology, vol. 60, no. 5, pp. 428–431, 2012. View at Publisher · View at Google Scholar · View at Scopus
  89. A. W. Stitt, T. M. Curtis, M. Chen et al., “The progress in understanding and treatment of diabetic retinopathy,” Progress in Retinal and Eye Research, vol. 51, pp. 156–186, 2016. View at Publisher · View at Google Scholar · View at Scopus
  90. X. Zhang, H. Zeng, S. Bao, N. Wang, and M. C. Gillies, “Diabetic macular edema: new concepts in patho-physiology and treatment,” Cell & Bioscience, vol. 4, no. 1, p. 27, 2014. View at Publisher · View at Google Scholar · View at Scopus
  91. G. Bergers and S. Song, “The role of pericytes in blood-vessel formation and maintenance,” Neuro-Oncology, vol. 7, no. 4, pp. 452–464, 2005. View at Publisher · View at Google Scholar · View at Scopus
  92. N. S. Harhaj and D. A. Antonetti, “Regulation of tight junctions and loss of barrier function in pathophysiology,” The International Journal of Biochemistry & Cell Biology, vol. 36, no. 7, pp. 1206–1237, 2004. View at Publisher · View at Google Scholar · View at Scopus
  93. J. Cunha-Vaz, R. Bernardes, and C. Lobo, “Blood-retinal barrier,” European Journal of Ophthalmology, vol. 21, Supplement 6, pp. S3–S9, 2011. View at Publisher · View at Google Scholar · View at Scopus
  94. A. M. Joussen, V. Poulaki, M. L. Le et al., “A central role for inflammation in the pathogenesis of diabetic retinopathy,” The FASEB Journal, vol. 18, no. 12, pp. 1450–1452, 2004. View at Publisher · View at Google Scholar · View at Scopus
  95. L. P. Aiello, R. L. Avery, P. G. Arrigg et al., “Vascular endothelial growth factor in ocular fluid of patients with diabetic retinopathy and other retinal disorders,” New England Journal of Medicine, vol. 331, no. 22, pp. 1480–1487, 1994. View at Publisher · View at Google Scholar · View at Scopus
  96. N. Ferrara, “Vascular endothelial growth factor: basic science and clinical progress,” Endocrine Reviews, vol. 25, no. 4, pp. 581–611, 2004. View at Publisher · View at Google Scholar · View at Scopus
  97. T. Y. Wong, C. M. Cheung, M. Larsen, S. Sharma, and R. Simo, “Diabetic retinopathy,” Nature Reviews Disease Primers, vol. 2, article 16012, 2016. View at Publisher · View at Google Scholar · View at Scopus
  98. H. Oh, H. Takagi, K. Suzuma, A. Otani, M. Matsumura, and Y. Honda, “Hypoxia and vascular endothelial growth factor selectively up-regulate angiopoietin-2 in bovine microvascular endothelial cells,” Journal of Biological Chemistry, vol. 274, no. 22, pp. 15732–15739, 1999. View at Publisher · View at Google Scholar · View at Scopus
  99. N. Ferrara, H. P. Gerber, and J. LeCouter, “The biology of VEGF and its receptors,” Nature Medicine, vol. 9, no. 6, pp. 669–676, 2003. View at Publisher · View at Google Scholar · View at Scopus
  100. P. Lindblom, H. Gerhardt, S. Liebner et al., “Endothelial PDGF-B retention is required for proper investment of pericytes in the microvessel wall,” Genes & Development, vol. 17, no. 15, pp. 1835–1840, 2003. View at Publisher · View at Google Scholar · View at Scopus
  101. G. Romeo, W. H. Liu, V. Asnaghi, T. S. Kern, and M. Lorenzi, “Activation of nuclear factor-kappaB induced by diabetes and high glucose regulates a proapoptotic program in retinal pericytes,” Diabetes, vol. 51, no. 7, pp. 2241–2248, 2002. View at Publisher · View at Google Scholar
  102. P. Geraldes, J. Hiraoka-Yamamoto, M. Matsumoto et al., “Activation of PKC-delta and SHP-1 by hyperglycemia causes vascular cell apoptosis and diabetic retinopathy,” Nature Medicine, vol. 15, no. 11, pp. 1298–1306, 2009. View at Publisher · View at Google Scholar · View at Scopus
  103. T. S. Devi, K. Hosoya, T. Terasaki, and L. P. Singh, “Critical role of TXNIP in oxidative stress, DNA damage and retinal pericyte apoptosis under high glucose: implications for diabetic retinopathy,” Experimental Cell Research, vol. 319, no. 7, pp. 1001–1012, 2013. View at Publisher · View at Google Scholar · View at Scopus
  104. T. S. Kern and B. A. Berkowitz, “Photoreceptors in diabetic retinopathy,” Journal of Diabetes Investigation, vol. 6, no. 4, pp. 371–380, 2015. View at Publisher · View at Google Scholar · View at Scopus
  105. Y. Du, A. Veenstra, K. Palczewski, and T. S. Kern, “Photoreceptor cells are major contributors to diabetes-induced oxidative stress and local inflammation in the retina,” Proceedings of the National Academy of Sciences, vol. 110, no. 41, pp. 16586–16591, 2013. View at Publisher · View at Google Scholar · View at Scopus
  106. G. B. Arden, “The absence of diabetic retinopathy in patients with retinitis pigmentosa: implications for pathophysiology and possible treatment,” British Journal of Ophthalmology, vol. 85, no. 3, pp. 366–370, 2001. View at Publisher · View at Google Scholar · View at Scopus
  107. T. E. de Gooyer, K. A. Stevenson, P. Humphries, D. A. Simpson, T. A. Gardiner, and A. W. Stitt, “Retinopathy is reduced during experimental diabetes in a mouse model of outer retinal degeneration,” Investigative Opthalmology & Visual Science, vol. 47, no. 12, pp. 5561–5568, 2006. View at Publisher · View at Google Scholar · View at Scopus
  108. S. Roy, T. S. Kern, B. Song, and C. Stuebe, “Mechanistic insights into pathological changes in the diabetic retina: implications for targeting diabetic retinopathy,” The American Journal of Pathology, vol. 187, no. 1, pp. 9–19, 2017. View at Publisher · View at Google Scholar
  109. C. M. Bergamini, S. Gambetti, A. Dondi, and C. Cervellati, “Oxygen, reactive oxygen species and tissue damage,” Current Pharmaceutical Design, vol. 10, no. 14, pp. 1611–1626, 2004. View at Publisher · View at Google Scholar · View at Scopus
  110. R. A. Kowluru and P. S. Chan, “Oxidative stress and diabetic retinopathy,” Experimental Diabetes Research, vol. 2007, Article ID 43603, 12 pages, 2007. View at Publisher · View at Google Scholar · View at Scopus
  111. R. C. Scarpulla, “Nucleus-encoded regulators of mitochondrial function: integration of respiratory chain expression, nutrient sensing and metabolic stress,” Biochimica et Biophysica Acta (BBA) - Gene Regulatory Mechanisms, vol. 2012, pp. 1088–1097, 1819. View at Publisher · View at Google Scholar · View at Scopus
  112. R. A. Kowluru and S. N. Abbas, “Diabetes-induced mitochondrial dysfunction in the retina,” Investigative Opthalmology & Visual Science, vol. 44, no. 12, pp. 5327–5334, 2003. View at Publisher · View at Google Scholar · View at Scopus
  113. W. Droge, “Free radicals in the physiological control of cell function,” Physiological Reviews, vol. 82, no. 1, pp. 47–95, 2002. View at Publisher · View at Google Scholar
  114. S. P. Narayanan, M. Rojas, J. Suwanpradid, H. A. Toque, R. W. Caldwell, and R. B. Caldwell, “Arginase in retinopathy,” Progress in Retinal and Eye Research, vol. 36, pp. 260–280, 2013. View at Publisher · View at Google Scholar · View at Scopus
  115. K. Miwa, J. Nakamura, Y. Hamada et al., “The role of polyol pathway in glucose-induced apoptosis of cultured retinal pericytes,” Diabetes Research and Clinical Practice, vol. 60, no. 1, pp. 1–9, 2003. View at Publisher · View at Google Scholar · View at Scopus
  116. S. Yamagishi, S. Maeda, T. Matsui, S. Ueda, K. Fukami, and S. Okuda, “Role of advanced glycation end products (AGEs) and oxidative stress in vascular complications in diabetes,” Biochimica et Biophysica Acta (BBA) - General Subjects, vol. 2012, pp. 663–671, 1820. View at Publisher · View at Google Scholar · View at Scopus
  117. D. XL, D. Edelstein, L. Rossetti et al., “Hyperglycemia-induced mitochondrial superoxide overproduction activates the hexosamine pathway and induces plasminogen activator inhibitor-1 expression by increasing Sp1 glycosylation,” Proceedings of the National Academy of Sciences, vol. 97, pp. 12222–12226, 2000. View at Publisher · View at Google Scholar · View at Scopus
  118. Y. Q. Chen, M. Su, R. R. Walia, Q. Hao, J. W. Covington, and D. E. Vaughan, “Sp1 sites mediate activation of the plasminogen activator inhibitor-1 promoter by glucose in vascular smooth muscle cells,” Journal of Biological Chemistry, vol. 273, no. 14, pp. 8225–8231, 1998. View at Publisher · View at Google Scholar · View at Scopus
  119. R. A. Kowluru, V. Kowluru, Y. Xiong, and Y. S. Ho, “Overexpression of mitochondrial superoxide dismutase in mice protects the retina from diabetes-induced oxidative stress,” Free Radical Biology and Medicine, vol. 41, no. 8, pp. 1191–1196, 2006. View at Publisher · View at Google Scholar · View at Scopus
  120. E. J. Mayer-Davis, R. A. Bell, B. A. Reboussin, J. Rushing, J. A. Marshall, and R. F. Hamman, “Antioxidant nutrient intake and diabetic retinopathy: the San Luis Valley diabetes study,” Ophthalmology, vol. 105, no. 12, pp. 2264–2270, 1998. View at Publisher · View at Google Scholar
  121. A. E. Millen, M. Gruber, R. Klein, B. E. Klein, M. Palta, and J. A. Mares, “Relations of serum ascorbic acid and alpha-tocopherol to diabetic retinopathy in the third National Health and Nutrition Examination Survey,” American Journal of Epidemiology, vol. 158, no. 3, pp. 225–233, 2003. View at Publisher · View at Google Scholar · View at Scopus
  122. J. J. Garcia-Medina, M. D. Pinazo-Duran, M. Garcia-Medina, V. Zanon-Moreno, and S. Pons-Vazquez, “A 5-year follow-up of antioxidant supplementation in type 2 diabetic retinopathy,” European Journal of Ophthalmology, vol. 21, no. 5, pp. 637–643, 2011. View at Publisher · View at Google Scholar · View at Scopus
  123. R. Pazdro and J. R. Burgess, “The role of vitamin E and oxidative stress in diabetes complications,” Mechanisms of Ageing and Development, vol. 131, no. 4, pp. 276–286, 2010. View at Publisher · View at Google Scholar · View at Scopus
  124. A. Jariyapongskul, T. Rungjaroen, N. Kasetsuwan, S. Patumraj, J. Seki, and H. Niimi, “Long-term effects of oral vitamin C supplementation on the endothelial dysfunction in the iris microvessels of diabetic rats,” Microvascular Research, vol. 74, no. 1, pp. 32–38, 2007. View at Publisher · View at Google Scholar · View at Scopus
  125. G. T. Mustata, M. Rosca, K. M. Biemel et al., “Paradoxical effects of green tea (Camellia sinensis) and antioxidant vitamins in diabetic rats: improved retinopathy and renal mitochondrial defects but deterioration of collagen matrix glycoxidation and cross-linking,” Diabetes, vol. 54, no. 2, pp. 517–526, 2005. View at Publisher · View at Google Scholar · View at Scopus
  126. R. A. Kowluru and S. Odenbach, “Effect of long-term administration of alpha-lipoic acid on retinal capillary cell death and the development of retinopathy in diabetic rats,” Diabetes, vol. 53, no. 12, pp. 3233–3238, 2004. View at Publisher · View at Google Scholar · View at Scopus
  127. H. P. Hammes, A. Bartmann, L. Engel, and P. Wulfroth, “Antioxidant treatment of experimental diabetic retinopathy in rats with nicanartine,” Diabetologia, vol. 40, no. 6, pp. 629–634, 1997. View at Publisher · View at Google Scholar · View at Scopus
  128. B. Kumar, S. K. Gupta, T. C. Nag, S. Srivastava, and R. Saxena, “Green tea prevents hyperglycemia-induced retinal oxidative stress and inflammation in streptozotocin-induced diabetic rats,” Ophthalmic Research, vol. 47, no. 2, pp. 103–107, 2012. View at Publisher · View at Google Scholar · View at Scopus
  129. H. P. Hammes, X. Du, D. Edelstein et al., “Benfotiamine blocks three major pathways of hyperglycemic damage and prevents experimental diabetic retinopathy,” Nature Medicine, vol. 9, no. 3, pp. 294–299, 2003. View at Publisher · View at Google Scholar · View at Scopus
  130. A. C. Keech, P. Mitchell, P. A. Summanen et al., “Effect of fenofibrate on the need for laser treatment for diabetic retinopathy (FIELD study): a randomised controlled trial,” The Lancet, vol. 370, no. 9600, pp. 1687–1697, 2007. View at Publisher · View at Google Scholar · View at Scopus
  131. Group AS, Group AES, E. Y. Chew, W. T. Ambrosius et al., “Effects of medical therapies on retinopathy progression in type 2 diabetes,” New England Journal of Medicine, vol. 363, no. 3, pp. 233–244, 2010. View at Publisher · View at Google Scholar · View at Scopus
  132. T. Y. Wong, R. Simo, and P. Mitchell, “Fenofibrate - a potential systemic treatment for diabetic retinopathy?” American Journal of Ophthalmology, vol. 154, pp. 6–12, 2012. View at Publisher · View at Google Scholar · View at Scopus
  133. S. Zhao, J. Li, N. Wang et al., “Fenofibrate suppresses cellular metabolic memory of high glucose in diabetic retinopathy via a sirtuin 1-dependent signalling pathway,” Molecular Medicine Reports, vol. 12, no. 4, pp. 6112–6118, 2015. View at Publisher · View at Google Scholar · View at Scopus
  134. I. Jialal and H. Kaur, “The role of Toll-like receptors in diabetes-induced inflammation: implications for vascular complications,” Current Diabetes Reports, vol. 12, no. 2, pp. 172–179, 2012. View at Publisher · View at Google Scholar · View at Scopus
  135. M. R. Dasu, S. Devaraj, L. Zhao, D. H. Hwang, and I. Jialal, “High glucose induces toll-like receptor expression in human monocytes: mechanism of activation,” Diabetes, vol. 57, no. 11, pp. 3090–3098, 2008. View at Publisher · View at Google Scholar · View at Scopus
  136. T. Coll, X. Palomer, F. Blanco-Vaca et al., “Cyclooxygenase 2 inhibition exacerbates palmitate-induced inflammation and insulin resistance in skeletal muscle cells,” Endocrinology, vol. 151, no. 2, pp. 537–548, 2010. View at Publisher · View at Google Scholar · View at Scopus
  137. H. Shi, M. V. Kokoeva, K. Inouye, I. Tzameli, H. Yin, and J. S. Flier, “TLR4 links innate immunity and fatty acid-induced insulin resistance,” Journal of Clinical Investigation, vol. 116, no. 11, pp. 3015–3025, 2006. View at Publisher · View at Google Scholar · View at Scopus
  138. M. R. Dasu and I. Jialal, “Free fatty acids in the presence of high glucose amplify monocyte inflammation via Toll-like receptors,” AJP: Endocrinology and Metabolism, vol. 300, no. 1, pp. E145–E154, 2011. View at Publisher · View at Google Scholar · View at Scopus
  139. X. X. Zeng, Y. K. Ng, and E. A. Ling, “Neuronal and microglial response in the retina of streptozotocin-induced diabetic rats,” Visual Neuroscience, vol. 17, no. 3, pp. 463–471, 2000. View at Publisher · View at Google Scholar · View at Scopus
  140. A. P. Adamis and A. J. Berman, “Immunological mechanisms in the pathogenesis of diabetic retinopathy,” Seminars in Immunopathology, vol. 30, no. 2, pp. 65–84, 2008. View at Publisher · View at Google Scholar · View at Scopus
  141. N. Demircan, B. G. Safran, M. Soylu, A. A. Ozcan, and S. Sizmaz, “Determination of vitreous interleukin-1 (IL-1) and tumour necrosis factor (TNF) levels in proliferative diabetic retinopathy,” Eye, vol. 20, no. 12, pp. 1366–1369, 2006. View at Publisher · View at Google Scholar · View at Scopus
  142. G. A. Limb, A. H. Chignell, W. Green, F. LeRoy, and D. C. Dumonde, “Distribution of TNF alpha and its reactive vascular adhesion molecules in fibrovascular membranes of proliferative diabetic retinopathy,” British Journal of Ophthalmology, vol. 80, no. 2, pp. 168–173, 1996. View at Publisher · View at Google Scholar
  143. A. M. Abu el Asrar, D. Maimone, P. H. Morse, S. Gregory, and A. T. Reder, “Cytokines in the vitreous of patients with proliferative diabetic retinopathy,” American Journal of Ophthalmology, vol. 114, no. 6, pp. 731–736, 1992. View at Publisher · View at Google Scholar
  144. C. A. Aveleira, C. M. Lin, S. F. Abcouwer, A. F. Ambrosio, and D. A. Antonetti, “TNF-α signals through pkcζ/NF-κB to alter the tight junction complex and increase retinal endothelial cell permeability,” Diabetes, vol. 59, no. 11, pp. 2872–2882, 2010. View at Publisher · View at Google Scholar · View at Scopus
  145. A. M. Joussen, V. Poulaki, N. Mitsiades et al., “Nonsteroidal anti-inflammatory drugs prevent early diabetic retinopathy via TNF-α suppression,” The FASEB Journal, vol. 17, no. 1, pp. 76–78, 2002. View at Publisher · View at Google Scholar
  146. X. Liu, F. Ye, H. Xiong et al., “IL-1β upregulates IL-8 production in human Müller cells through activation of the p38 MAPK and ERK1/2 signaling pathways,” Inflammation, vol. 37, no. 5, pp. 1486–1495, 2014. View at Publisher · View at Google Scholar · View at Scopus
  147. Y. Du, V. P. Sarthy, and T. S. Kern, “Interaction between NO and COX pathways in retinal cells exposed to elevated glucose and retina of diabetic rats,” AJP: Regulatory, Integrative and Comparative Physiology, vol. 287, no. 4, pp. R735–R741, 2004. View at Publisher · View at Google Scholar · View at Scopus
  148. J. Wang, X. Xu, M. H. Elliott, M. Zhu, and Y. Z. Le, “Muller cell-derived VEGF is essential for diabetes-induced retinal inflammation and vascular leakage,” Diabetes, vol. 59, no. 9, pp. 2297–2305, 2010. View at Publisher · View at Google Scholar · View at Scopus
  149. A. M. Joussen, V. Poulaki, N. Mitsiades et al., “Suppression of Fas-FasL-induced endothelial cell apoptosis prevents diabetic blood-retinal barrier breakdown in a model of streptozotocin-induced diabetes,” FASEB Journal, vol. 17, no. 1, pp. 76–78, 2003. View at Publisher · View at Google Scholar
  150. A. M. Joussen, T. Murata, A. Tsujikawa, B. Kirchhof, S. E. Bursell, and A. P. Adamis, “Leukocyte-mediated endothelial cell injury and death in the diabetic retina,” The American Journal of Pathology, vol. 158, no. 1, pp. 147–152, 2001. View at Publisher · View at Google Scholar
  151. E. Ducharme and J. M. Weinberg, “Etanercept,” Expert Opinion on Biological Therapy, vol. 8, no. 4, pp. 491–502, 2008. View at Publisher · View at Google Scholar · View at Scopus
  152. A. M. Joussen, S. Doehmen, M. L. Le et al., “TNF-alpha mediated apoptosis plays an important role in the development of early diabetic retinopathy and long-term histopathological alterations,” Molecular Vision, vol. 15, pp. 1418–1428, 2009. View at Google Scholar
  153. Y. Behl, P. Krothapalli, T. Desta, A. DiPiazza, S. Roy, and D. T. Graves, “Diabetes-enhanced tumor necrosis factor-α production promotes apoptosis and the loss of retinal microvascular cells in type 1 and type 2 models of diabetic retinopathy,” The American Journal of Pathology, vol. 172, no. 5, pp. 1411–1418, 2008. View at Publisher · View at Google Scholar · View at Scopus
  154. Y. Behl, P. Krothapalli, T. Desta, S. Roy, and D. T. Graves, “FOXO1 plays an important role in enhanced microvascular cell apoptosis and microvascular cell loss in type 1 and type 2 diabetic rats,” Diabetes, vol. 58, no. 4, pp. 917–925, 2009. View at Publisher · View at Google Scholar · View at Scopus
  155. M. K. Tsilimbaris, T. D. Panagiotoglou, S. K. Charisis, A. Anastasakis, T. S. Krikonis, and E. Christodoulakis, “The use of intravitreal etanercept in diabetic macular oedema,” Seminars in Ophthalmology, vol. 22, no. 2, pp. 75–79, 2007. View at Publisher · View at Google Scholar · View at Scopus
  156. F. Ghadiri Soufi, E. Arbabi-Aval, M. Rezaei Kanavi, and H. Ahmadieh, “Anti-inflammatory properties of resveratrol in the retinas of type 2 diabetic rats,” Clinical and Experimental Pharmacology and Physiology, vol. 42, no. 1, pp. 63–68, 2015. View at Publisher · View at Google Scholar · View at Scopus
  157. S. H. Kim, J. H. Park, Y. J. Kim, and K. H. Park, “The neuroprotective effect of resveratrol on retinal ganglion cells after optic nerve transection,” Molecular Vision, vol. 19, pp. 1667–1676, 2013. View at Google Scholar
  158. J. A. Vincent and S. Mohr, “Inhibition of caspase-1/interleukin-1β signaling prevents degeneration of retinal capillaries in diabetes and galactosemia,” Diabetes, vol. 56, pp. 224–230, 2007. View at Publisher · View at Google Scholar · View at Scopus
  159. R. A. Kowluru and S. Odenbach, “Role of interleukin-1β in the development of retinopathy in rats: effect of antioxidants,” Investigative Opthalmology & Visual Science, vol. 45, no. 11, pp. 4161–4166, 2004. View at Publisher · View at Google Scholar · View at Scopus
  160. S. Mohr, X. Xi, J. Tang, and T. S. Kern, “Caspase activation in retinas of diabetic and galactosemic mice and diabetic patients,” Diabetes, vol. 51, no. 4, pp. 1172–1179, 2002. View at Publisher · View at Google Scholar
  161. F. Yulek, M. Or, C. Ozogul et al., “Effects of stobadine and vitamin E in diabetes-induced retinal abnormalities: involvement of oxidative stress,” Archives of Medical Research, vol. 38, pp. 503–511, 2007. View at Publisher · View at Google Scholar · View at Scopus
  162. W. L. Wong, X. Su, X. Li et al., “Global prevalence of age-related macular degeneration and disease burden projection for 2020 and 2040: a systematic review and meta-analysis,” Lancet Globalization and Health, vol. 2, pp. e106–e116, 2014. View at Publisher · View at Google Scholar · View at Scopus
  163. J. Z. Nowak, “Age-related macular degeneration (AMD): pathogenesis and therapy,” Pharmacological Reports, vol. 58, no. 3, pp. 353–363, 2006. View at Google Scholar
  164. K. M. Gehrs, D. H. Anderson, L. V. Johnson, and G. S. Hageman, “Age-related macular degeneration—emerging pathogenetic and therapeutic concepts,” Annals of Medicine, vol. 38, no. 7, pp. 450–471, 2006. View at Publisher · View at Google Scholar · View at Scopus
  165. H. R. Coleman, C. C. Chan, F. L. Ferris 3rd, and E. Y. Chew, “Age-related macular degeneration,” Lancet, vol. 372, no. 9652, pp. 1835–1845, 2008. View at Publisher · View at Google Scholar · View at Scopus
  166. M. R. Kozlowski, “RPE cell senescence: a key contributor to age-related macular degeneration,” Medical Hypotheses, vol. 78, no. 4, pp. 505–510, 2012. View at Publisher · View at Google Scholar · View at Scopus
  167. J. Ambati, J. P. Atkinson, and B. D. Gelfand, “Immunology of age-related macular degeneration,” Nature Reviews Immunology, vol. 13, no. 6, pp. 438–451, 2013. View at Publisher · View at Google Scholar · View at Scopus
  168. Y. DY and S. J. Cringle, “Retinal degeneration and local oxygen metabolism,” Experimental Eye Research, vol. 80, pp. 745–751, 2005. View at Publisher · View at Google Scholar · View at Scopus
  169. B. S. Winkler, M. E. Boulton, J. D. Gottsch, and P. Sternberg, “Oxidative damage and age-related macular degeneration,” Molecular Vision, vol. 5, p. 32, 1999. View at Google Scholar
  170. M. V. Miceli, M. R. Liles, and D. A. Newsome, “Evaluation of oxidative processes in human pigment epithelial cells associated with retinal outer segment phagocytosis,” Experimental Cell Research, vol. 214, no. 1, pp. 242–249, 1994. View at Publisher · View at Google Scholar · View at Scopus
  171. I. Johansson, V. T. Monsen, K. Pettersen et al., “The marine n-3 PUFA DHA evokes cytoprotection against oxidative stress and protein misfolding by inducing autophagy and NFE2L2 in human retinal pigment epithelial cells,” Autophagy, vol. 11, no. 9, pp. 1636–1651, 2015. View at Publisher · View at Google Scholar · View at Scopus
  172. L. Wang, M. Cano, S. Datta et al., “Pentraxin 3 recruits complement factor H to protect against oxidative stress-induced complement and inflammasome overactivation,” The Journal of Pathology, vol. 240, no. 4, pp. 495–506, 2016. View at Publisher · View at Google Scholar · View at Scopus
  173. D. F. Church and W. A. Pryor, “Free-radical chemistry of cigarette smoke and its toxicological implications,” Environmental Health Perspectives, vol. 64, pp. 111–126, 1985. View at Publisher · View at Google Scholar
  174. S. E. Moriarty, J. H. Shah, M. Lynn et al., “Oxidation of glutathione and cysteine in human plasma associated with smoking,” Free Radical Biology and Medicine, vol. 35, no. 12, pp. 1582–1588, 2003. View at Publisher · View at Google Scholar · View at Scopus
  175. M. Fujihara, N. Nagai, T. E. Sussan, S. Biswal, and J. T. Handa, “Chronic cigarette smoke causes oxidative damage and apoptosis to retinal pigmented epithelial cells in mice,” PLoS One, vol. 3, no. 9, article e3119, 2008. View at Publisher · View at Google Scholar · View at Scopus
  176. C. L. Nordgaard, P. P. Karunadharma, X. Feng, T. W. Olsen, and D. A. Ferrington, “Mitochondrial proteomics of the retinal pigment epithelium at progressive stages of age-related macular degeneration,” Investigative Opthalmology & Visual Science, vol. 49, no. 7, pp. 2848–2855, 2008. View at Publisher · View at Google Scholar · View at Scopus
  177. G. S. Hageman, D. H. Anderson, L. V. Johnson et al., “A common haplotype in the complement regulatory gene factor H (HF1/CFH) predisposes individuals to age-related macular degeneration,” Proceedings of the National Academy of Sciences, vol. 102, no. 20, pp. 7227–7232, 2005. View at Publisher · View at Google Scholar · View at Scopus
  178. S. O'Neill, J. Brault, M. J. Stasia, and U. G. Knaus, “Genetic disorders coupled to ROS deficiency,” Redox Biology, vol. 6, pp. 135–156, 2015. View at Publisher · View at Google Scholar · View at Scopus
  179. M. Boulton, M. Rozanowska, and B. Rozanowski, “Retinal photodamage,” Journal of Photochemistry and Photobiology B: Biology, vol. 64, no. 2-3, pp. 144–161, 2001. View at Publisher · View at Google Scholar · View at Scopus
  180. A. Kijlstra, Y. Tian, E. R. Kelly, and T. T. Berendschot, “Lutein: more than just a filter for blue light,” Progress in Retinal and Eye Research, vol. 31, no. 4, pp. 303–315, 2012. View at Publisher · View at Google Scholar · View at Scopus
  181. S. Johnsen-Soriano, M. Garcia-Pous, E. Arnal et al., “Early lipoic acid intake protects retina of diabetic mice,” Free Radical Research, vol. 42, no. 7, pp. 613–617, 2008. View at Publisher · View at Google Scholar · View at Scopus
  182. J. M. Woo, D. Y. Shin, S. J. Lee et al., “Curcumin protects retinal pigment epithelial cells against oxidative stress via induction of heme oxygenase-1 expression and reduction of reactive oxygen,” Molecular Vision, vol. 18, pp. 901–908, 2012. View at Google Scholar
  183. H. Chen, J. T. Tran, R. E. Anderson, and M. N. Mandal, “Caffeic acid phenethyl ester protects 661W cells from H2O2-mediated cell death and enhances electroretinography response in dim-reared albino rats,” Molecular Vision, vol. 18, pp. 1325–1338, 2012. View at Google Scholar
  184. Age-Related Eye Disease Study Research G, “A randomized, placebo-controlled, clinical trial of high-dose supplementation with vitamins C and E, beta carotene, and zinc for age-related macular degeneration and vision loss,” Archives of Ophthalmology, vol. 119, no. 10, pp. 1417–1436, 2001. View at Publisher · View at Google Scholar
  185. Group AR, E. Y. Chew, T. Clemons et al., “The age-related eye disease study 2 (AREDS2): study design and baseline characteristics (AREDS2 report number 1),” Ophthalmology, vol. 119, no. 11, pp. 2282–2289, 2012. View at Publisher · View at Google Scholar · View at Scopus
  186. J. G. Hollyfield, V. L. Bonilha, M. E. Rayborn et al., “Oxidative damage-induced inflammation initiates age-related macular degeneration,” Nature Medicine, vol. 14, no. 2, pp. 194–198, 2008. View at Publisher · View at Google Scholar · View at Scopus
  187. J. Zhou, Y. P. Jang, S. R. Kim, and J. R. Sparrow, “Complement activation by photooxidation products of A2E, a lipofuscin constituent of the retinal pigment epithelium,” Proceedings of the National Academy of Sciences, vol. 103, no. 44, pp. 16182–16187, 2006. View at Publisher · View at Google Scholar · View at Scopus
  188. M. Zhang, G. Xu, W. Liu, Y. Ni, and W. Zhou, “Role of fractalkine/CX3CR1 interaction in light-induced photoreceptor degeneration through regulating retinal microglial activation and migration,” PLoS One, vol. 7, no. 12, article e35446, 2012. View at Publisher · View at Google Scholar · View at Scopus
  189. J. V. Glenn and A. W. Stitt, “The role of advanced glycation end products in retinal ageing and disease,” Biochimica et Biophysica Acta (BBA) - General Subjects, vol. 1790, no. 10, pp. 1109–1116, 2009. View at Publisher · View at Google Scholar · View at Scopus
  190. W. Ma, S. Coon, L. Zhao, R. N. Fariss, and W. T. Wong, “A2E accumulation influences retinal microglial activation and complement regulation,” Neurobiology of Aging, vol. 34, no. 3, pp. 943–960, 2013. View at Publisher · View at Google Scholar · View at Scopus
  191. D. Yang, S. G. Elner, X. Chen, M. G. Field, H. R. Petty, and V. M. Elner, “MCP-1-activated monocytes induce apoptosis in human retinal pigment epithelium,” Investigative Opthalmology & Visual Science, vol. 52, no. 8, pp. 6026–6034, 2011. View at Publisher · View at Google Scholar · View at Scopus
  192. M. Suzuki, M. Tsujikawa, H. Itabe et al., “Chronic photo-oxidative stress and subsequent MCP-1 activation as causative factors for age-related macular degeneration,” Journal of Cell Science, vol. 125, no. 10, pp. 2407–2415, 2012. View at Publisher · View at Google Scholar · View at Scopus
  193. J. L. Ren, J. S. Pan, L. YP, P. Sun, and J. Han, “Inflammatory signaling and cellular senescence,” Cellular Signalling, vol. 21, no. 3, pp. 378–383, 2009. View at Publisher · View at Google Scholar · View at Scopus
  194. R. K. Kutty, W. Samuel, K. Boyce et al., “Proinflammatory cytokines decrease the expression of genes critical for RPE function,” Molecular Vision, vol. 22, pp. 1156–1168, 2016. View at Google Scholar
  195. M. C. Marazita, A. Dugour, M. D. Marquioni-Ramella, J. M. Figueroa, and A. M. Suburo, “Oxidative stress-induced premature senescence dysregulates VEGF and CFH expression in retinal pigment epithelial cells: implications for age-related macular degeneration,” Redox Biology, vol. 7, pp. 78–87, 2016. View at Publisher · View at Google Scholar · View at Scopus
  196. M. R. Damani, L. Zhao, A. M. Fontainhas, J. Amaral, R. N. Fariss, and W. T. Wong, “Age-related alterations in the dynamic behavior of microglia,” Aging Cell, vol. 10, no. 2, pp. 263–276, 2011. View at Publisher · View at Google Scholar · View at Scopus
  197. F. Cruz-Guilloty, A. M. Saeed, J. J. Echegaray et al., “Infiltration of proinflammatory m1 macrophages into the outer retina precedes damage in a mouse model of age-related macular degeneration,” International Journal of Inflammation, vol. 2013, Article ID 503725, 12 pages, 2013. View at Publisher · View at Google Scholar · View at Scopus
  198. C. Zhao, D. Yasumura, X. Li et al., “mTOR-mediated dedifferentiation of the retinal pigment epithelium initiates photoreceptor degeneration in mice,” Journal of Clinical Investigation, vol. 121, no. 1, pp. 369–383, 2011. View at Publisher · View at Google Scholar · View at Scopus
  199. W. T. Wong, S. Dresner, F. Forooghian et al., “Treatment of geographic atrophy with subconjunctival sirolimus: results of a phase I/II clinical trial,” Investigative Opthalmology & Visual Science, vol. 54, no. 4, pp. 2941–2950, 2013. View at Publisher · View at Google Scholar · View at Scopus
  200. P. A. Petrou, D. Cunningham, K. Shimel et al., “Intravitreal sirolimus for the treatment of geographic atrophy: results of a phase I/II clinical trial,” Investigative Opthalmology & Visual Science, vol. 56, no. 1, pp. 330–338, 2014. View at Publisher · View at Google Scholar · View at Scopus
  201. M. J. Geerlings, E. K. de Jong, and A. I. den Hollander, “The complement system in age-related macular degeneration: a review of rare genetic variants and implications for personalized treatment,” Molecular Immunology, vol. 84, pp. 65–76, 2017. View at Publisher · View at Google Scholar · View at Scopus
  202. W. Rhoades, D. Dickson, and D. V. Do, “Potential role of lampalizumab for treatment of geographic atrophy,” Clinical Ophthalmology, vol. 9, pp. 1049–1056, 2015. View at Publisher · View at Google Scholar · View at Scopus
  203. S. Datta, M. Cano, K. Ebrahimi, L. Wang, and J. T. Handa, “The impact of oxidative stress and inflammation on RPE degeneration in non-neovascular AMD,” Progress in Retinal and Eye Research, vol. 60, pp. 201–218, 2017. View at Publisher · View at Google Scholar
  204. J. Gao, R. T. Liu, S. Cao et al., “NLRP3 inflammasome: activation and regulation in age-related macular degeneration,” Mediators of Inflammation, vol. 2015, Article ID 690243, 11 pages, 2015. View at Publisher · View at Google Scholar · View at Scopus
  205. V. Tarallo, Y. Hirano, B. D. Gelfand et al., “DICER1 loss and Alu RNA induce age-related macular degeneration via the NLRP3 inflammasome and MyD88,” Cell, vol. 149, no. 4, pp. 847–859, 2012. View at Publisher · View at Google Scholar · View at Scopus
  206. N. Kerur, Y. Hirano, V. Tarallo et al., “TLR-independent and P2X7-dependent signaling mediate Alu RNA-induced NLRP3 inflammasome activation in geographic atrophy,” Investigative Opthalmology & Visual Science, vol. 54, no. 12, pp. 7395–7401, 2013. View at Publisher · View at Google Scholar · View at Scopus
  207. B. J. Fowler, B. D. Gelfand, Y. Kim et al., “Nucleoside reverse transcriptase inhibitors possess intrinsic anti-inflammatory activity,” Science, vol. 346, no. 6212, pp. 1000–1003, 2014. View at Publisher · View at Google Scholar · View at Scopus
  208. L. J. Roberts 2nd, J. P. Fessel, and S. S. Davies, “The biochemistry of the isoprostane, neuroprostane, and isofuran pathways of lipid peroxidation,” Brain Pathology, vol. 15, no. 2, pp. 143–148, 2006. View at Publisher · View at Google Scholar